|
Derpha Laboratories and the Jacques Vernin Institute: Natural products whose effectiveness is so rapid that you can directly link what you take to what you feel. |
|
4 Patented Technologies |
45 to 55% Plant Extract Concentration |
0 Animal Testing |
|
The Institute's research has led to new plant extraction technologies that concentrate, stabilize, and make biologically available the active ingredients of plants, with measurable, reproducible, and clinically proven efficacy. |
|
I) First Objective Liquid Plant Extracts for Cosmetology |
The skin exchanges, breathes, and secretes. Traditional plant remedies showed beneficial results but remained unsuitable for the modern world. The Institute changed that.
|
01 Extraction Select, extract, concentrate, and stabilize the active ingredients of each plant. |
02 Amplification Magnify the activity potential of extracted components to maximize their action. |
03 Bioavailability Connection with cellular receptors, ensuring the effectiveness of active ingredients. |
|
45 to 55% plant extracts in formulas. Clinical tests on humans in hospital settings. No animal testing. Organic quality farming contracts. |
| 01 |
Consistency and Safety of Plants Selection with the National Conservatory of Medicinal Plants and ITEPMAI, applying the model of fine vineyards to phytotherapy. |
| 02 |
Extraction and Stabilization Technologies Processes specifically adapted to each plant to preserve the integrity of beneficial active ingredients. |
| 03 |
Identification and Dosage of Active Ingredients Each extract is standardized to ensure reproducibility and consistent efficacy from one dose to another. |
| 04 |
Clinical Tests on Humans Validated in dermatological or hospital settings. Synergistic combinations with proven efficacy. No animal testing. |
| 05 |
Exceptional Formulation A special excipient incorporates 45 to 55% plant extracts, unique proportions in global cosmetology. |
|
II) Second Objective TITREX® & PHYTOFLOR®: Standardized Concentrated Extracts |
TITREX® (oral) and PHYTOFLOR® (topical): standardized extracts 5 to 20 times more concentrated than raw plants, produced at low temperatures to preserve all active ingredients.
|
5 to 20× Concentration vs. raw plant |
35°C max Vacuum concentration for total preservation of active ingredients |
≤ 60° Alcohol: never beyond to avoid toxic substances |
|
Three Drying Procedures
|
Clinical Guarantees
|
|
III) Third Objective Micro-Encapsulated Essential Oils |
Exposed to air, an essential oil oxidizes within days and becomes pro-oxidant and allergenic. The Institute has reinvented their protection, mimicking how plants do it in their closed organs.
|
The Problem
|
The Solution
|
|
"First, do no harm" Founding principle of the Jacques Vernin Institute, at the origin of every technological choice. |
|
IV) Fourth Objective PHYTESCENS®: Global Patent |
Combining plant extracts and essential oils in stable synergies was previously impossible. PHYTESCENS® made it possible and patented it worldwide.
|
Innovation Awarded with a Global Patent |
|||||||||||||
|
+ |
|
= |
|
|||||||||
|
01 Rapid Results Noticeable effectiveness from the first doses |
02 Immediate Efficacy Targeted actives addressing the root cause |
03 Perfect Tolerance Clinically proven, with no side effects |
|
V) Derpha's Holistic Approach Three Ranges to Cover Your Entire Body |
Our body is composed of a fatty phase (brain, nervous system, cell membranes, hormonal glands) and an aqueous phase. Derpha products address both simultaneously.
|
Fatty Phase Oleo-Essentiels® Essential fatty acids for the brain, nervous system, and cell membranes. |
Aqueous Phase TITREX® Capsules 5 to 20× concentrated extracts. Targeted nutrients for cellular receptors. |
Global Synergy PHYTESCENS® Capsules Diffuse in both phases to reach the target at the origin of acute or chronic conditions. |
|
Plant Alchemy Quality, efficacy, and experience make our difference. For decades, the Jacques Vernin Institute has pushed the boundaries of what nature can offer to human health. |